Results 201 to 210 of about 6,048,873 (298)
Impact of Clinical Pharmacy Team Intervention on Naloxone Fills in Patients on ChroCnic Opioid Therapy. [PDF]
Sijapati RS, Himes ER, Hale SA.
europepmc +1 more source
Clinical Pharmacy Education in a Dental Pharmacy
John A. Walker, Dennis K. Helling
openaire +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
Implementation of Clinical Pharmacy Services in Primary Health Care: A Scoping Review. [PDF]
Paolinelli JPV +4 more
europepmc +1 more source
L‐cysteine‐configured chiral polyurethane nanoparticles suppress ocular inflammation and reduce extracellular matrix (ECM) degradation in ectopia lentis by regulating macrophages polarization and inhibiting nuclear factor kappa B signaling pathway. By promoting zonular fiber‐associated protein restoration and tissue repair, this minimally invasive ...
Yinuo Wen +17 more
wiley +1 more source
Role of basic chemistry education in clinical pharmacy requirements: evidence from cross-sectional study and narrative review. [PDF]
Zhang Y +7 more
europepmc +1 more source
. ABSTRACT Neuroinflammation driven by microglial activation is a defining feature of Alzheimer's disease (AD), yet the molecular mechanisms sustaining this proinflammatory state remain unclear. Here, we identify the deubiquitinase OTUD7B as a critical regulator of microglial activation and AD pathology.
Luyao Li +15 more
wiley +1 more source
Identifying patient data that should be available in community pharmacies for statutory dispensing and providing clinical pharmacy services: A Delphi study. [PDF]
Laakso J +3 more
europepmc +1 more source
The mechanism diagram of VDAC1 mediating neuronal excitability and neuropathic pain. Briefly, VDAC1 is expressed in DRG neurons and is upregulated following CCI‐induced neuropathic pain. This upregulation enhances ATP transport from mitochondria to the cytoplasm in sensory neurons, leading to increased neuronal excitability and pain behavior.
Fengrun Sun +7 more
wiley +1 more source
Impact of Artificial Intelligence on the Future of Clinical Pharmacy and Hospital Settings. [PDF]
Hamishehkar H, Shahidi M.
europepmc +1 more source

